| Assets | — | — |
| Current assets | — | — |
| Cash and cash equivalents | 2,715.41a | 6,494.95a |
| Marketable securities | 2,171.48a | 0a |
| Other current assets | 113.17a | 80.61a |
| Current assets of discontinued operations | 0a | 156.27a |
| Total current assets | 5,000.06a | 6,731.83a |
| Property and equipment, net | 12.06a | 15.32a |
| Operating lease right-of-use assets | 89.02a | 44a |
| Investments measured at fair value | 302.94a | 247.75a |
| Other assets | 32.86a | 37.7a |
| Noncurrent assets of discontinued operations | 0a | 145.88a |
| Total assets | 5,436.94a | 7,222.48a |
| Liabilities and shareholders’ equity | — | — |
| Current liabilities | — | — |
| Accounts payable | 23.69a | 14.03a |
| Accrued expenses | 114.29a | 119.42a |
| Operating lease liabilities | 9.84a | 8.97a |
| Other current liabilities | 1.58a | 13.94a |
| Current liabilities of discontinued operations | 0a | 110.41a |
| Total current liabilities | 149.41a | 266.76a |
| Liability instruments measured at fair value | 9.98a | 25.74a |
| Operating lease liabilities, noncurrent | 90.33a | 45.02a |
| Other liabilities | 0.02a | 2.49a |
| Noncurrent liabilities of discontinued operations | 0a | 433.95a |
| Total liabilities | 249.74a | 773.95a |
| Shareholders’ equity | — | — |
| Common shares | 0a | 0a |
| Additional paid-in capital | 4,562.11a | 5,396.49a |
| Retained earnings | 116.06a | 576.17a |
| Accumulated other comprehensive income (loss) | 9.44a | -4.08a |
| Shareholders’ equity attributable to Roivant Sciences Ltd. | 4,687.61a | 5,968.58a |
| Noncontrolling interests | 499.59a | 479.95a |
| Total shareholders’ equity | 5,187.2a | 6,448.53a |
| Total liabilities and shareholders’ equity | 5,436.94a | 7,222.48a |